BioIndustry Association Manufacturing Advisory Committee Leadership Programme - BIA MAC LeaP 

The development and training  of managers in the biopharmaceutical and cell and gene therapy industries is a key part of delivering the senior leaders of the future. 

The BIA MAC LeaP programme supports this initiative in two key ways.  Our programme supports cross-sector learning by offering an overview of the work of companies across biopharma, vaccines and cell and gene therapies by visiting work sites and seeing their work in action. 

We have created and support a peer network which shares best practice and develops relationships to encourage possible future collaborations.

The pilot programme was launched in January 2017 and completed in January 2019, following which an alumni group has been set up to support ongoing networking. On the back of the success of the pilot, a second programme is well underway, starting in January 2018, and a third double cohort started in January 2019. Currently 44 participants from 23 member companies are benefitting from LeaP.   

Latest LeaP News 

A glimpse into life at GSK 

A mini tour of AdaptImmune 

LeaP Testimonials 

For more information on LeaP 

LeaP Programme Details 

Senior Leader in Advanced therapies 

Annette England

Bioprocessing Consultant

BIA

Annette is an external consultant with 28 years bioprocessing experience, who has supported three main bioprocessing projects within BIA since April 2014 – Manufacturing Advisory Committee (MAC), Medicines Manufacturing Industry Partnership (MMIP) and the Annual bioProcessUK Conference.

Annette has been a consultant since 2003, working with a range of academic and industrial organisations, and prior to that spent over 15 years in bioprocess development working for Ludwig Institute for Cancer Research, British Biotech and Applikon Biotechnology. She gained a BSc in Biological Sciences and an MSc in Biochemical Engineering from Birmingham University.